Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole. [electronic resource]
Producer: 20030602Description: 657-62 p. digitalISSN:- 0163-2116
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Adult
- Benzimidazoles -- adverse effects
- Double-Blind Method
- Esophagitis, Peptic -- diagnosis
- Female
- Gastroesophageal Reflux -- diagnosis
- Humans
- Male
- Middle Aged
- Omeprazole -- analogs & derivatives
- Outcome Assessment, Health Care -- statistics & numerical data
- Patient Satisfaction
- Proton-Translocating ATPases -- adverse effects
- Psychometrics
- Rabeprazole
- Randomized Controlled Trials as Topic
- Sick Role
No physical items for this record
Publication Type: Clinical Trial; Evaluation Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.